{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":7,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":7,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"21bfcc07159b","filters":{"venue":"Clinical Lymphoma"}},"results":[{"id":"W1983990351","doi":"10.3816/clm.2003.n.024","title":"Primary Adrenal Lymphoma","year":2003,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Incidence (geometry); Disease; Regimen; Adrenal insufficiency; Chemotherapy; Radiation therapy; Internal medicine; Oncology; Surgery","authors":[{"name":"Andrew Grigg","is_ca":false},{"name":"Joseph M. Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1218755038252844,"gpt":0.420515326986854,"spread":0.2986398231615697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001048228,0.0009037554,0.005299722,0.0002363926,0.0001246093,0.00003959236,0.0004705723,0.001348925,0.0008367029],"category_scores_gemma":[0.0006231881,0.0006393799,0.003220093,0.0006620373,0.000458238,0.0000646705,0.0001961802,0.0004743644,0.004663955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004347925,"about_ca_system_score_gemma":0.00369537,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006388863,"about_ca_topic_score_gemma":8.040259e-7,"domain_scores_codex":[0.9940907,0.0005779474,0.002743235,0.001196644,0.0006188196,0.0007726133],"domain_scores_gemma":[0.9956132,0.001189645,0.0008415545,0.001286135,0.0001397512,0.0009296943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008535958,0.0008474043,0.00003337556,0.00774259,0.0004375621,0.006280737,0.00000404763,1.307603e-8,4.859596e-9,0.0002591499,0.01869769,0.9656121],"study_design_scores_gemma":[0.002906402,0.0004540914,0.001093893,0.01192565,0.002801674,0.0208179,0.00000290348,0.000001145286,1.934071e-7,0.00008119407,0.959275,0.0006399446],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009543734,0.9589422,0.00002332147,0.00004783535,0.001734237,0.0009765247,0.00006755316,0.0001912446,0.03792164],"genre_scores_gemma":[0.000009134758,0.9745672,0.0005996117,0.002130537,0.002013933,0.00009406756,0.0005782744,0.0001788176,0.01982837],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9649721,"threshold_uncertainty_score":0.9999475,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092788376","doi":"10.3816/clm.2002.s.006","title":"Acute and Long-Term Toxicities Associated with Gemtuzumab Ozogamicin (Mylotarg®) Therapy of Acute Myeloid Leukemia","year":2002,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Myeloid leukemia; Calicheamicin; Medicine; Leukemia; Pharmacology; Oncology; Internal medicine; CD33; Biology; Stem cell","authors":[{"name":"Lance Leopold","is_ca":true},{"name":"Mark S. Berger","is_ca":false},{"name":"Jay Feingoldr","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07021262687105202,"gpt":0.3669513961079253,"spread":0.2967387692368733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005485048,0.001259037,0.00659026,0.0002997285,0.0001190602,0.00004893789,0.0004970373,0.00154098,0.0003678443],"category_scores_gemma":[0.0002390465,0.0008525389,0.00136248,0.0005633746,0.001010946,0.0001231705,0.0002283817,0.000728361,0.0001068312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003792473,"about_ca_system_score_gemma":0.003181963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003404609,"about_ca_topic_score_gemma":0.00001835733,"domain_scores_codex":[0.9940115,0.0004819529,0.00256045,0.001342626,0.0007656983,0.0008377286],"domain_scores_gemma":[0.9944013,0.001712198,0.001731534,0.001416167,0.0002208775,0.0005179049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005060988,0.0007808047,0.003004184,0.002339523,0.01570144,0.001544941,0.00007050011,5.323472e-8,0.000002317912,0.00001295574,0.000754692,0.9752825],"study_design_scores_gemma":[0.113226,0.02205307,0.1000758,0.1329391,0.07391068,0.007570526,0.00004729254,0.00008954991,0.0001372398,0.00005975518,0.5451201,0.004770799],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.133934,0.8621321,0.000004878889,0.00003378586,0.0003186216,0.002016651,0.0004605383,0.0001759724,0.0009234978],"genre_scores_gemma":[0.00215492,0.9894756,0.0001922637,0.0002726379,0.0003845413,0.0001331333,0.001030791,0.0002724303,0.006083661],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9705117,"threshold_uncertainty_score":0.9997552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102070406","doi":"10.3816/clm.2005.n.002","title":"Origins of Waldenström's Macroglobulinemia: Does It Arise from an Unusual B-Cell Precursor?","year":2005,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canada Research Chairs","keywords":"Immunoglobulin class switching; Somatic hypermutation; Waldenstrom macroglobulinemia; Immunoglobulin D; Macroglobulinemia; B cell; Biology; Immunoglobulin M; CD40; Cytidine deaminase; Monoclonal gammopathy of undetermined significance; Immunology; Molecular biology; Antibody; Monoclonal; Genetics; Monoclonal antibody; Immunoglobulin G; Multiple myeloma; Cytotoxic T cell; Lymphoma","authors":[{"name":"Jitra Kriangkum","is_ca":true},{"name":"Brian J. Taylor","is_ca":true},{"name":"Tony Reiman","is_ca":true},{"name":"Andrew R. Belch","is_ca":true},{"name":"Linda M. Pilarski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09611683324481807,"gpt":0.4676728339755265,"spread":0.3715560007307084,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001447739,0.001146246,0.006456437,0.0003233906,0.00009110642,0.00007180866,0.001454582,0.00278055,0.001104436],"category_scores_gemma":[0.0015865,0.0007633998,0.002472515,0.0006894022,0.001105386,0.0001568905,0.0006386361,0.001340205,0.001660653],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02474583,"about_ca_system_score_gemma":0.03633261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001570325,"about_ca_topic_score_gemma":0.0002104697,"domain_scores_codex":[0.9900248,0.0008790612,0.004415204,0.002023197,0.001479121,0.00117862],"domain_scores_gemma":[0.9898269,0.003819003,0.001418605,0.003041427,0.0004231176,0.001470998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003852871,0.002724034,0.00005164682,0.008053953,0.0006440518,0.001089546,0.00005791482,4.501747e-7,7.887736e-7,0.000112405,0.004067169,0.9828128],"study_design_scores_gemma":[0.01861822,0.0009953203,0.00003884205,0.01038344,0.003706826,0.0003797451,0.00004519231,0.0003563589,0.00003578831,0.00005008847,0.964662,0.000728161],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01111795,0.9801843,0.00001661315,0.0001813118,0.001488748,0.002138696,0.0009928915,0.0001933455,0.003686193],"genre_scores_gemma":[0.0009448976,0.985649,0.001895396,0.0004185358,0.005242692,0.0001197863,0.001338632,0.0002737324,0.00411727],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9820846,"threshold_uncertainty_score":0.9998087,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974738398","doi":"10.3816/clm.2005.n.030","title":"A Randomized Phase III Study of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin as Salvage Chemotherapy Followed by Posttransplantation Rituximab Maintenance Therapy Versus Observation for Treatment of Aggressive B-Cell and T-Cell Non-Hodgkin's Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Salvage therapy; Etoposide; Internal medicine; Oncology; Vincristine; Gemcitabine; Cytarabine; Carboplatin; Febrile neutropenia; Surgery; Chemotherapy; Rituximab; Neutropenia; Cyclophosphamide; Cisplatin; Lymphoma","authors":[{"name":"Michael Crump","is_ca":true},{"name":"Lois E. Shepherd","is_ca":true},{"name":"Boris K. Lin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04579541808009396,"gpt":0.3648090888550763,"spread":0.3190136707749824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008738994,0.0006692137,0.002569867,0.0001721621,0.0001510902,0.00004360023,0.0001217987,0.0003518415,0.00002025761],"category_scores_gemma":[0.0004842803,0.0005121028,0.0004218715,0.0002628249,0.0004641099,0.0002091971,0.00003074048,0.00005607582,0.000002244831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002130921,"about_ca_system_score_gemma":0.0002354565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005857235,"about_ca_topic_score_gemma":0.00007320231,"domain_scores_codex":[0.9959782,0.000354808,0.001754908,0.001007714,0.0004424096,0.0004619636],"domain_scores_gemma":[0.9905121,0.006696046,0.001631393,0.0005179634,0.0003003585,0.000342178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6331185,0.0308992,0.01870614,0.000161597,0.001481904,0.00006063108,0.002247288,0.000002720473,0.006218845,0.00003846294,0.0002089776,0.3068558],"study_design_scores_gemma":[0.8992887,0.03060926,0.03963176,0.0001843921,0.001850623,0.0000245364,0.0006165365,0.002805586,0.02422631,0.00002676087,0.0003261617,0.0004093448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872584,0.005663087,0.0002560087,0.0003467474,0.000239265,0.005814325,0.0001885713,0.00004275375,0.0001907901],"genre_scores_gemma":[0.9739192,0.0176965,0.006919248,0.0002025756,0.0001136355,0.0006735006,0.000242682,0.00007873736,0.0001539908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3064464,"threshold_uncertainty_score":0.999733,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079316702","doi":"10.3816/clm.2005.n.010","title":"Potential Impact of a Single Nucleotide Polymorphism in the Hyaluronan Synthase 1 Gene in Waldenström's Macroglobulinemia","year":2005,"lang":"en","type":"article","venue":"Clinical Lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"RNA splicing; Single-nucleotide polymorphism; Hyaluronan synthase; Gene; Biology; Intron; Genetics; Molecular biology; Genotype; RNA","authors":[{"name":"Sophia Adamia","is_ca":true},{"name":"Steven P. Treon","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"Olivier Tournilhac","is_ca":false},{"name":"Carrie McQuarrie","is_ca":true},{"name":"Michael J. Mant","is_ca":true},{"name":"Andrew R. Belch","is_ca":true},{"name":"Linda M. Pilarski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03790136286088836,"gpt":0.3723077149982262,"spread":0.3344063521373379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00177853,0.0002902326,0.00081658,0.0002448395,0.00004069448,0.00002920666,0.0005542318,0.0003348105,0.0003717227],"category_scores_gemma":[0.00128404,0.0001991463,0.0005990936,0.0006385216,0.0005732519,0.0001048315,0.0001988651,0.0003774864,0.0001836571],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006856105,"about_ca_system_score_gemma":0.005176132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002796614,"about_ca_topic_score_gemma":0.0003726775,"domain_scores_codex":[0.9959157,0.0004130803,0.001543237,0.000575793,0.000761466,0.0007907191],"domain_scores_gemma":[0.997438,0.0009301627,0.0002216519,0.0009933063,0.0001014112,0.0003155024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007836008,0.01337808,0.0964465,0.0001814155,0.0003402472,0.0107831,0.0009067363,0.0006171024,0.02341021,0.000122187,0.004655536,0.8413229],"study_design_scores_gemma":[0.08456311,0.004039716,0.8635104,0.0004896006,0.0001806271,0.003377812,0.0002275405,0.03663098,0.003970917,0.0001922059,0.002288021,0.0005290935],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956229,0.000604422,0.00001599005,0.001476176,0.0001646355,0.0006251368,0.00003023702,0.00003271881,0.001427733],"genre_scores_gemma":[0.9972182,0.0001045653,0.0007952226,0.0007103652,0.0008389968,0.00002149201,0.00002969783,0.00004742587,0.0002340433],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8407938,"threshold_uncertainty_score":0.9969564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090941758","doi":"10.3816/clm.2005.n.028","title":"ABVD, the Stanford V Regimen, and BEACOPP for Hodgkin's Lymphoma: What Should an Oncologist Do?","year":2005,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Vincristine; Regimen; Vinblastine; Dacarbazine; Bleomycin; Prednisone; Etoposide; Internal medicine; Oncology; Hodgkin's lymphoma; Lymphoma; Chemotherapy; Cyclophosphamide","authors":[{"name":"Joseph M. Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2624196302931387,"gpt":0.4975247917156729,"spread":0.2351051614225342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002117911,0.001201335,0.004691003,0.0001686707,0.0004245979,0.0006822029,0.0006925105,0.001670927,0.00007057711],"category_scores_gemma":[0.0008531851,0.0006761185,0.002068258,0.0003350437,0.0009642459,0.0005467517,0.0003361818,0.0002738046,0.0001153145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001257069,"about_ca_system_score_gemma":0.002094342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004293895,"about_ca_topic_score_gemma":0.00006889296,"domain_scores_codex":[0.9935453,0.0005454554,0.002547664,0.001782038,0.0006218179,0.0009577426],"domain_scores_gemma":[0.9903712,0.005310973,0.001119555,0.002094454,0.0002516027,0.0008522492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003113973,0.002848635,0.0001860947,0.002117384,0.0009969174,0.0002110124,0.00004332305,5.785703e-8,1.947336e-8,0.001254444,0.01600187,0.9760289],"study_design_scores_gemma":[0.01014183,0.003189292,0.001770467,0.007640158,0.00670079,0.0007017378,0.0001678582,0.00001107169,8.724381e-7,0.0001496046,0.9688385,0.0006878515],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006815971,0.9891603,0.00001707484,0.002203792,0.001519107,0.004944464,0.0002648277,0.0001723989,0.001036412],"genre_scores_gemma":[0.0002742703,0.9866936,0.001258695,0.004069848,0.002979121,0.001836862,0.000732544,0.0001981349,0.001956937],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.975341,"threshold_uncertainty_score":0.9996251,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1994225339","doi":"10.3816/clm.2003.n.019","title":"Lymphomas and Oncolytic Virus Therapy","year":2003,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Blood Services; Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"","keywords":"Oncolytic virus; Viral therapy; Virology; Lymphoma; Virus; Cancer therapy; Medicine; Cancer; Immunology; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Infectious disease (medical specialty)","authors":[{"name":"Tommy Alain","is_ca":true},{"name":"Chandini M. Thirukkumaran","is_ca":true},{"name":"Donald G. Morris","is_ca":true},{"name":"Stefan J. Urbanski","is_ca":true},{"name":"Anna Janowska‐Wieczorek","is_ca":true},{"name":"Patrick W.K. Lee","is_ca":true},{"name":"Anna E. Kossakowska","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1193231851807176,"gpt":0.4431997913370223,"spread":0.3238766061563046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001384551,0.0006621892,0.001751179,0.0001095978,0.0001345252,0.00008272915,0.0006725256,0.001310757,0.0001411503],"category_scores_gemma":[0.0003215707,0.0004718353,0.0009705765,0.0002435802,0.000510198,0.000003401527,0.0002598963,0.0002493754,0.0002614476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008536404,"about_ca_system_score_gemma":0.00159921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000782689,"about_ca_topic_score_gemma":0.00002495239,"domain_scores_codex":[0.9954793,0.00115878,0.001183326,0.001251123,0.0003090564,0.0006184297],"domain_scores_gemma":[0.9974944,0.0002924624,0.0003666847,0.00131274,0.0001010724,0.000432632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003962892,0.0003008133,0.00001567384,0.000496604,0.0004059173,0.00002657013,0.00000256303,5.132743e-8,0.00004945268,0.00001350477,0.003182473,0.9951101],"study_design_scores_gemma":[0.001921838,0.003575701,0.00002004907,0.0004869536,0.0001350982,0.0001159631,0.000002542511,0.00000128343,0.0001879221,0.00005019042,0.9929119,0.0005904937],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00239521,0.9947034,0.000007019428,0.00002167579,0.0004696969,0.0008822922,0.00006846971,0.00002805337,0.001424187],"genre_scores_gemma":[0.00004843775,0.994365,0.0001018289,0.0007508772,0.0008429016,0.0001607602,0.0002090489,0.0001738783,0.003347265],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9945196,"threshold_uncertainty_score":0.9999858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}